CTNM Market Cap & Key Metrics
Contineum Therapeutics, Inc. Class A Common Stock
$8.14
-$0.28(-3.33%)
46
Overall
60
Value
45
Tech
34
Quality
Market Cap
$306.24M
Volume
1.01M
52W Range
$8.60 - $17.79
Target Price
$21.83
CTNM market cap is $306.24M. This page lists Contineum Therapeutics, Inc. Class A Common Stock's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CTNM Key Metrics
- Market cap
- $306.24M
- EPS estimate, current year
- $-1.68
- EPS growth, 3-year
- +41.45%
- Value score
- 60
- Quality score
- 34
- Technical score
- 45
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | - | - | $50.00M | - |
| EBITDA | -$57.89M | -$41.13M | $20.70M | - |
| EPS | $-2.17 | $-2.18 | $1.36 | $-10.81 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $8.14 | -3.3% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics, Inc. Class A Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW